Cell Line Development Services and Cell Line Characterization Services Market Revenue to Cross US$ 4.4 billion and US$ 3.9 billion, respectively by 2035

Published: February 2024


According to a recently published report by Roots Analysis, the growing pipeline of biologics, and the ongoing research and innovation have led to an increase in the demand for productive and high-quality cell lines, creating lucrative opportunities for cell line service providers.

Cell Line Characterization and Cell Line Development Industry Overview

The global cell line development services and cell line characterization services market is anticipated to grow at a CAGR of 12.5% from 2024-2035, reaching USD 4.4 billion and USD 3.9 billion respectively by 2035.

Cell lines, cultured populations of cells, have become a crucial part of the biopharmaceutical industry; they are a valuable tool for screening potential drug candidates, developing biologics, studying biology of chronic diseases and assessing toxicity of drugs. Most of the cell lines used today are derived from humans, mice and rats; however, some of them are also derived from other mammalian and non-mammalian species.  Notably, increasing advancements in genome editing technology have opened new avenues for cell line development. Further, the developed cell lines are characterized and authenticated to determine their origin / history and identify key characteristics and functionality. However, the development and characterization of cell lines is both technically challenging and financially demanding; as a result, drug developers are becoming increasingly dependent on contract service providers for their advanced technologies, infrastructure and expertise.

Browse 140+ figures and 205+ market data tables spread across 445+ pages and detailed Table of Content on “Cell Line Characterization and Cell Line Development Market: Industry Trends and Global Forecasts, till 2035, by Source of Cell Lines, Application of Cell Lines, Company Size and Key Geographical Regions” here: https://www.rootsanalysis.com/reports/cell-line-development-and-characterization-services.html

Market Drivers

Cell lines are invaluable tools, currently being explored and used by academic and research institutes to conduct basic research, experimentation and collaborative projects. Several factors are propelling the growth of the cell line development and characterization market including adoption of personalized medicine and increasing demand of cell line-based therapies. Various service providers are focused on incorporating novel technologies in their cell line development (genetic engineering and cell culture optimization) and characterization (high throughput screening) approaches, further improving the quality of biopharmaceuticals developed from their cell lines. Moreover, the rising interest in personalized and regenerative medicines has led to rise in demand for specialized cell lines customized for individual patient needs.

Market Restraints

While the cell line development and characterization market is experiencing substantial growth, there are various restraints that can hinder the growth of the industry. One of the primary restraints related to the cell line development and cell line characterization is the high cost associated with establishing specialized facilities and sophisticated equipment. Another factor is the difficulty in maintaining consistent quality on larger scales, which leads to an increase in the production costs. Further, the companies with insufficient technical expertise may struggle to optimize the cell line development process, resulting in low yield and wastage of resources. Moreover, the stringent regulatory requirements to ensure the quality of cell lines developed /characterized can also hinder the growth.

Growth Factors

Despite the challenges, several growth factors continue to drive the cell line development and characterization market forward. Notably, the increasing prevalence of chronic diseases drives the demand for cell lines to produce novel biologics, such as monoclonal antibodies, recombinant proteins and vaccines. Additionally, the increasing collaborations between different stakeholders in this domain, and preference for outsourcing cell line development and characterization operations also foster market growth.

Cell Line Characterization and Cell Line Development Market Segments

Based on the source of cell lines, the market is segmented into mammalian cell lines, microbial cell lines, insect cell lines and others.

  • The mammalian cell line segment led the market for cell line development and cell line characterization, capturing the largest revenue share of close to 75% and 70%, respectively in 2024.
  • The mammalian cell line segment is anticipated to be the fastest growing segment in cell line development as well as cell line characterization services market with an annualized rate of over 12.5%, during the forecast period.

Based on the application of cell lines, the market is segmented into bioproduction, and research and development.

  • The bioproduction segment led the market for cell line development and cell line characterization, capturing the largest revenue share of more than 85% and 70%, respectively in 2024.
  • The research and development segment is anticipated to be the fastest growing segments in cell line development as well as cell line characterization services market with an annualized rate of more than 15% and 12.5%, respectively during the forecast period.

Based on the company size, the market is segmented into small, mid-sized and large companies.

  • The mid-sized companies led the market for cell line development and cell line characterization, capturing the largest revenue share of around 40% in both the forecasts, in 2024.
  • The small companies’ segment is anticipated to be the fastest growing segment in cell line development as well as cell line characterization services market with an annualized rate of around 14% during the forecast period.

Based on the Regional Insights, the market is segmented into North America, Europe, Asia Pacific and Rest of the World

  • North America dominated the cell line development and characterization services market and accounted for the largest revenue share of over 40% in both the forecasts, in 2024.
  • In North America, the cell line development and cell line characterization services market is anticipated to demonstrate lucrative growth (13% and 15%, respectively) during the forecast period.

Key Companies Profiled

The cell line characterization and cell line development market report also include detailed profiles of key players (listed below) that offer cell line development and characterization services:

Cell Line Development Service Providers

  • ATUM
  • Biovian
  • Celonic
  • ChemPartner
  • Creative Biogene
  • Curia
  • FUJIFILM Diosynth Biotechnologies
  • KBI Biopharma
  • Kemp Proteins
  • KMD Bioscience
  • Lonza
  • Mycenax Biotech
  • ProBioGen
  • Syngene International, 
  • Thermo Fisher Scientific
  • WuXi Biologics

Cell Line Characterization Service Providers

  • ATZ Labs
  • Avance Biosciences
  • BioReliance
  • Charles River Laboratories
  • Cleancells
  • Eurofins BioPharma Product Testing
  • Hylabs
  • Livogen Pharmed 
  • Molecular Diagnostic Services
  • Samsung BioLogics
  • Sartorius
  • SGS Life Sciences
  • Texcell
  • TFBS Bioscience
  • WuXi Advanced Therapies

You Can Download Free Sample PDF Copy of This Report at:
https://www.rootsanalysis.com/reports/cell-line-development-and-characterization-services/request-sample.html

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

Contact Details

Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com

MEDIA CITATIONS

  • We are your partners with no equity

  • We fit in your budget

  • We love what we do

  • Chance to prove ourselves

  • Best in class quality of work

  • Most trusted consulting partner in the industry